Major cannabis multistate operators have poured millions into Donald Trump's political action committees, which are now funneling money to support a Senate candidate with a hard-line anti-marijuana voting record.
The donations raise questions about the industry's political strategy as federal reform efforts stall. Several top MSOs contributed to Trump-aligned PACs in recent months, apparently betting on broader regulatory or tax benefits that could outweigh the administration's mixed signals on cannabis policy.
But those same PACs are now backing Senate candidates who've consistently opposed marijuana legalization and reform measures. The disconnect has sparked criticism from reform advocates who argue the industry is undermining its own policy goals.
The Money Trail
Cannabis companies have contributed at least several million dollars to Trump-affiliated committees since the 2024 election cycle began. The exact figures remain murky due to disclosure timing, but federal election filings show a sharp uptick in cannabis industry donations to Republican-aligned PACs.
Those contributions come despite Trump's inconsistent stance on cannabis. While he's suggested support for state-level legalization and hinted at federal banking reform, his administration appointees include several vocal opponents of marijuana policy changes.
Now some of that industry money is flowing to candidates who've voted against even modest reforms like the SAFE Banking Act. The Senate candidate in question has opposed marijuana legalization throughout their career and voted against medical cannabis protections in previous legislative roles.
Industry Response
Several MSO executives have defended the donations as pragmatic politics. The industry faces crushing tax burdens under Section 280E and needs Republican support to advance reform legislation in a divided Congress.
"We're supporting candidates who can help us on taxes and business issues," one industry lobbyist said, speaking on background. "Cannabis policy isn't the only thing that matters for our survival."
But reform advocates aren't buying it. They argue the donations signal the industry prioritizes profits over policy progress, potentially abandoning smaller operators and social equity applicants who can't afford to play both sides.
The National Cannabis Industry Association declined to comment directly on member companies' donation strategies. But the group has previously emphasized the importance of building bipartisan support for federal reforms.
What's Next
The Senate race in question could determine control of the chamber, giving cannabis donors an incentive to support the candidate despite their prohibitionist record. If Republicans take the majority, committee chairmanships would shift to members who've historically opposed marijuana reform.
That could complicate efforts to pass banking reform or advance marijuana rescheduling. The DEA's review of cannabis scheduling remains stalled, and congressional action on SAFE Banking or broader legalization appears unlikely before the 2024 election.
Meanwhile, the donations highlight a broader tension in cannabis lobbying. Large MSOs have different priorities than smaller operators, craft growers, and social equity licensees. As the industry matures, those divisions are becoming harder to paper over with unity messaging.
Some state-level operators are now questioning whether national trade groups truly represent their interests. If deep-pocketed MSOs continue backing anti-cannabis candidates, smaller players may need to organize separately to advance reform.
The Senate candidate's campaign did not respond to requests for comment on their marijuana policy positions.
This article is based on original reporting by mjbizdaily.com.
